The Fondazione IRCCS Policlinico San Matteo (IRCCSOSM)
Partner Information uitklapper, klik om te openen
The Fondazione IRCCS Policlinico San Matteo (IRCCSOSM, sited in Pavia, Italy) has been a Public Healthcare and Research Institution since 1982. With 3,500 employees, 861 beds and an annual financial budget that exceeds 400 million euros, IRCCSOSM is the largest organization in the Pavia area. In collaboration with the University of Pavia, the Hospital promotes teaching, training, professional and scientific qualification of medical and technical-assistance staff, and research is integrated with clinical practice.
The Cardiology and Intensive Care Unit Departments of IRCCSOSM are of national excellence and regional referral centres (Lombardia region, 10 million in habitats) for patients with cardiomyopathies, advanced heart failure and refractory ventricular arrhythmias Relevant facilities for STOPSTORM include the Cardiomyopathy and Hearth Failure Unit, and the Electrophysiology Unit.
The Cardiomyopathy and Heart Failure Unit has specialised expertise in cardiomyopathies, pulmonary hypertension, heart failure conditions, and management of cardiac transplanted patients.
The Electrophysiology Unit has specialised expertise in cardiac arrhythmias, electrophysiology, and pacing. The invasive procedures performed include trans-catheter ablation of a variety of atrial and ventricular arrhythmias, using advanced mapping systems and technologies. In addition, the unit has developed a unique expertise in neuromodulation strategies to manage refractory ventricular arrhythmias.
The Radiology Department of IRCCSOSM is a national excellence and a regional referral centre with a long-standing experience in thoracic and cardiac imaging.
In collaboration with CNAO, the Cardiology and Radiology Departments of IRCCSOSM have delivered STAR treatment to one patient using protons (December 2019), this was de first case worldwide. The treatment involved pre-procedural CT imaging, electrophysiological target definition (combination of invasive and non-invasive), and follow-up included cardiac CT and PET/CT.
In addition, a collaborative program of close cardiac monitoring for patients undergoing thoracic particle therapy for cancer at CNAO is ongoing since May 2019.
Personnel uitklapper, klik om te openen
Dr. Roberto Rordorf
Dr. Roberto Rordorf is Head of the EP Unit at the Cardiology Department, as well as Contract Professsor of Cardiology at the University of Pavia. In STOPSTORM he will mainly be involved in patient selection and in the definition of the target of treatment by means of invasive and non-invasive mapping of ventricular arrhythmias (WP2 and WP3). He will also be involved in ICD programming and in patients’ follow-up. Finally, he will contribute to the observational cohort (WP1) and to dissemination activities (WP7).
Dr. Veronica Dusi
Dr. Veronica Dusi is a clinical electrophysiologist working in the EP Unit at the Cardiology Department, who has recently completed a PhD program (University of Pavia) on neuromodulation to treat refractory ventricular arrhythmias in patients with structural heart disease. In STOPSTORM she will be mainly involved in patient selection and in the definition of the target of treatment by means of invasive and non-invasive mapping of ventricular arrhythmias (WP2 and WP3). She will also be involved in ICD programming and in patients’ follow-up. Finally, she will contribute to the observational cohort (WP1) and to dissemination activities (WP7).
Dr. Adele Valentini
Dr. Adele Valentini is a radiologist working in the Radiology Department of IRCCSOSM with extensive experience in thoracic and cardiac imaging (both cardiac CT and cardiac magnetic resonance). In STOPSTORM she will be involved in the execution and evaluation of the pre procedural CT imaging and post-procedural CT for the follow-up of the patients (WP2 and WP3).
Publications uitklapper, klik om te openen
- Rordorf R, Cornara S, Klersy C, et al. Incidence of appropriate anti-tachycardia therapies after elective generator replacement in patient with heart failure initially implanted with a defibrillator for primary prevention: Results of a meta-analysis. Int J Cardiol 2019; 283: 122-7.
- Savastano S, Pugliese L, Baldi E, Dusi V, Tavazzi G, De Ferrari GM. Percutaneous continuous left stellate ganglion block as an effective bridge to bilateral cardiac sympathetic denervation.. Europace 2020; pii: euaa007.
- De Ferrari GM, Dusi V, Ruffinazzi M, et al. ESCAPE-NET Investigators. Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION. Int J Cardiol 2020; 302: 164-170.
- De Ferrari GM, Dusi V, Spazzolini C, et al. Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation 2015; 131: 2185-93.
- Rampinelli C, Cicchetti G, Cortese G, et al. Management of incidental pulmonary nodule in CT: a survey by the Italian College of Chest Radiology. Radiol Med 2019; 124: 602-12.